YAP1 and hepatocellular carcinoma: Furthermore, targeting Hepatitis B X-interacting protein (HBXIP), which potentiates its effects by upregulating YAP through the transcription factor c-myb coactivation in HCC cells, prevents cancer cell proliferation (90).